Baseline characteristics stratified according to admission diagnosis
| Number of patients (%) | |||
|---|---|---|---|
| Characteristics | STEACS (n=62) | NSTEACS (n=78) | p Value |
| Age, years | 62.0±11.8 | 65.7±11.2 | 0.403 (+) |
| Sex, M/F | 47/15 | 61/17 | 0.840 (*) |
| Current smoker | 31 (50%) | 48 (61.5%) | 0.230 (*) |
| Medical history | |||
| Systolic hypertension | 41 (66%) | 64 (82%) | 0.049 (*) |
| Dyslipidaemia | 27 (43%) | 45 (58%) | 0.126 (*) |
| Diabetes | 12 (19%) | 24 (31%) | 0.173 (*) |
| Previous myocardial infarction | 9 (14%) | 33 (42%) | <0.0001 (*) |
| COPD | 10 (16%) | 24 (31%) | 0.050 (*) |
| Medications at admission | |||
| Aspirin | 61 (98%) | 77 (99%) | >0.999 (*) |
| Clopidogrel | 17 (27%) | 35 (45%) | 0.052 (*) |
| Prasugrel | 31 (50%) | 11 (14%) | <0.001 (*) |
| Ticagrelor | 5 (8%) | 23 (29%) | 0.002 (*) |
| Oral anticoagulant therapy | 3 (5%) | 12 (15%) | 0.057 (*) |
| β-Blockers | 54 (87%) | 61 (78%) | 0.121 (*) |
| Renin–angiotensin system | 53 (88%) | 61 (78%) | 0.266 (*) |
| Blockers | |||
| Diagnostic findings | |||
| Tryptase, ng/mL | 4.68 (1.17–14.5) | 5.2 (1.06–16.3) | 0.192 (+) |
| CRP, mg/dL | 0.3 (0–48) | 0.3 (0–2.9) | 0.808 (+) |
| Troponin HS, ng/L | 2025 (9–19 685) | 363 (6–10 713) | <0.0001 (+) |
| Serum triglycerides, mg/dL | 107 (45–311) | 118 (50–345) | 0.109 (+) |
| HDL cholesterol, mg/dL | 42 (18–84) | 41 (19–81) | 0.864 (+) |
| LDL cholesterol, mg/dL | 106.4 (±29.8) | 111.5 (±33.6) | 0.372 (++) |
| Plasma glucose, mg/dL | 133 (78–295) | 112 (60–403) | 0.011 (+) |
| Left ventricle ejection fraction during index hospitalisation | |||
| Ejection fraction | 48 (25–60) | 48 (30–64) | 0.837 (++) |
Values are n (%) or median and range or mean+SD depending on the distribution. Comparison performed by Mann-Whitney U test (+), Student's t-test (++) and Fisher's exact (*) tests.
COPD, chronic obstructive pulmonary disease; CRP, serum C reactive protein; F, female; HDL, high-density lipoprotein; HS, high-sensitive; LDL, low-density lipoprotein; M, male; NSTEACS, non-ST-elevation acute coronary syndrome; STEACS, ST-elevation acute coronary syndrome.